Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has ...

Dr Reddy’s Laboratories ( ($RDY) ) has provided an update. Dr. Reddy’s Laboratories announced on November 24, 2025, that it has received European ...

Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP), the European Commission has granted marketing authorizations for Teva's biosimilars PONLIMSI and DEGEVMA e ...

The latest update is out from Alvotech ( (ALVO) ).

Dr Reddy's Laboratories has received European Commission authorisation for AVT03, a biosimilar of Prolia and Xgeva, used to treat osteoporosis.

The EMA’s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, ...

Shares of Amgen are up nearly 26% this year and have soared 11% just over the past week.

Regeneron announced the FDA’s approval of two indications of Eylea HD, including an 8mg injection for patients with macular ...

Osteoporosis occurs more commonly in women, for whom medical guidelines recommend universal screening after age 65. But about ...

Today, Benzinga's options scanner spotted 9 options trades for Amgen. This is not a typical pattern. The sentiment among ...

The company's arm received approval from GIDC on Nov. 24, 2025, for the transfer of rights in leasehold land measuring about ...

Anti-vaccine sentiment is alive and well, especially in the U.S. And it was evident in recent weeks as drugmakers revealed ...